Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178230 · ClinicalTrials.gov registry record
Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity
A clinical trial of Lung Neoplasms, sponsored by University of Rochester.
- Completed
- Registry status
- 82
- Enrollment target
- 1
- Study location
NCT00178230 is a study of Lung Neoplasms that has completed, run by University of Rochester. The registered enrollment target is 82 participants, below the 463-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00178230, a study of Lung Neoplasms, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- 82 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being conducted by the University of Rochester Cancer Center to determine the levels of cytokines in the blood, and to determine if blood levels of these cytokines are related to the side effects of radiation therapy combined with other treatments.
Conditions Studied
Study Locations (1)
New York
- University of Rochester, Dept. Radiation Oncology - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 1996-03-15 |
| Est. Completion | 2013-11-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00178230
The ClinicalTrials.gov registry entry for NCT00178230 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 463-participant average among 22 other Lung Neoplasms trials with a reported enrollment target (82% lower). The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lung Neoplasms appearing as the primary indexed condition, and to 0 interventions.
NCT00178230 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00178230 about?
NCT00178230 is a clinical study titled "Circulating Cytokines as Predictors of Radiation Induced Pulmonary Toxicity". This study is being conducted by the University of Rochester Cancer Center to determine the levels of cytokines in the blood, and to determine if blood levels of these cytokines are related to the side effects of radiation therapy combined with other treatments.
What is the current status of trial NCT00178230?
This trial is currently completed. The enrollment target is 82 participants. The study started on 1996-03-15. Estimated completion is 2013-11-25.
What conditions does trial NCT00178230 study?
This clinical trial studies the following conditions: Lung Neoplasms.
Who is sponsoring clinical trial NCT00178230?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00178230 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Neoplasms
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Real World Registry for Use of the Ion Endoluminal System
RECRUITING
-
Specimen Banking From Patients With Lung Cancer
RECRUITING
-
TELESCOPE- TELEhealth Shared Decision-making COaching
RECRUITING · NA
-
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for Hispanics
RECRUITING · NA
-
Circulating Tumor Cells (CTC) in Lung Cancer
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.